<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Patel | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/brickchief3/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/brickchief3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Patel.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">61f0941fc12137f255b17df32a3f98a7</guid>
				<title>Patel posted an update: The polysaccharide inhibitor from red seaweed laver could be [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42195/</link>
				<pubDate>Sun, 09 Feb 2025 08:06:35 -0800</pubDate>

									<content:encoded><![CDATA[<p>The polysaccharide inhibitor from red seaweed laver could be regarded as a novel functional food ingredient in T2DM management.Alfalfa polysaccharide (APS) has been proposed to exhibit growth-promoting and immune-enhancing bodily functions in vivo. However, little is known about its downstream immunomodulatory and intrinsic molecular mechanisms.&hellip;<span class="activity-read-more" id="activity-read-more-42195"><a href="http://www.nationalboardinstitute.com/activity/p/42195/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">74cb0c09efe6d5ea45cc6d8d01261d80</guid>
				<title>Patel posted an update: Based on a recently published in silico analysis of more [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33155/</link>
				<pubDate>Thu, 30 Jan 2025 08:05:28 -0800</pubDate>

									<content:encoded><![CDATA[<p>Based on a recently published in silico analysis of more than 1600 family GH57 sequences, 13 GBE-like and 18 4AGT-like proteins from unique sources were collected and analyzed in a detail with respect to their taxonomical origin, sequence and structural features as well as evolutionary relationships. This in silico study could accelerate the&hellip;<span class="activity-read-more" id="activity-read-more-33155"><a href="http://www.nationalboardinstitute.com/activity/p/33155/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5cce909b0846d5852003f6aaf0db054b</guid>
				<title>Patel posted an update: the communication needs of people with ASD. Others, such as [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31152/</link>
				<pubDate>Tue, 28 Jan 2025 16:18:07 -0800</pubDate>

									<content:encoded><![CDATA[<p>the communication needs of people with ASD. Others, such as obesity, can lead to an array of other conditions, disadvantages and early mortality. It is essential that potentially modifiable physical conditions are identified to ensure people with ASD achieve their best outcomes. Heightening clinicians&#8217; awareness is important to aid in assessments&hellip;<span class="activity-read-more" id="activity-read-more-31152"><a href="http://www.nationalboardinstitute.com/activity/p/31152/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a2bc41e5e301963ac73d23af1a2b842e</guid>
				<title>Patel became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31135/</link>
				<pubDate>Tue, 28 Jan 2025 16:15:42 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>